Update on Antifungal Medication Coverage Determination Requests following 2012 Meningitis Outbreak
Guidance for Part D sponsors to expedite all coverage determination requests for voriconazole, and other appropriate antifungal medications, due to the meningitis outbreak associated with contaminated steroid products produced by the New England Compounding Center (NECC).
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: March 07, 2014
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.